Autolus Therapeutics Files 8-K with Investor Event Data
Ticker: AUTL · Form: 8-K · Filed: Apr 8, 2026 · CIK: 0001730463
| Field | Detail |
|---|---|
| Company | Autolus Therapeutics PLC (AUTL) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, investor-relations, filing-update
TL;DR
Autolus dropped new investor decks on 8-K, check for updates.
AI Summary
Autolus Therapeutics plc filed an 8-K on April 8, 2026, to disclose information under Regulation FD. The filing includes an investor event presentation, which contains various graphics and exhibits related to the company's operations and strategy. Specific financial figures or material business updates beyond the presentation itself are not detailed in the provided filing information.
Why It Matters
This filing provides investors with updated information and presentation materials from an Autolus Therapeutics investor event, offering insights into the company's current status and future outlook.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of an investor event presentation and does not contain new material financial information or significant business changes that would inherently increase risk.
Key Players & Entities
- Autolus Therapeutics plc (company) — Filer of the 8-K
- 0001730463 (company) — CUSIP number for Autolus Therapeutics plc
- 2026-04-08 (date) — Filing date and period of report
FAQ
What type of information is primarily contained in the exhibits of this 8-K filing?
The exhibits primarily consist of an investor event presentation, including numerous graphic files (e.g., ex-991allinvestoreventap001.jpg through ex-991allinvestoreventap032.jpg).
What are the main items disclosed in this 8-K filing?
This 8-K filing primarily discloses information under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 8, 2026, at 16:17:09.
What is the accession number for this specific SEC filing?
The SEC accession number for this filing is 0001730463-26-000043.
Does the filing detail specific financial statements or material contracts?
While Item 9.01 mentions Financial Statements and Exhibits, the provided details focus on the exhibits being an investor event presentation, not specific financial statements or contracts.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2026 regarding Autolus Therapeutics plc (AUTL).